南京金斯瑞生物科技有限公司 GenScript(Nanjing)Co.Ltd.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
GenScript Biotech Releases 2023 ESG Report: Deepening Green Development Practices, Constructing Sustainable Future Blueprint 2024-04-24 22:31
GenScript Biotech officially joins SBTi to fulfill its sustainability commitment 2024-04-15 15:04
GenScript Biotech Announces 2023 Annual Results with a Five-Year CAGR stands at 30% 2024-03-12 20:15
San Francisco Witnesses the Voice of GCT Titans GenScript Biotech Global Forum Outlines the Future of the Industry 2024-01-12 23:28
GenScript, GenScript ProBio, and Legend Biotech Will Attend the 42nd JPM Healthcare Conference, Advancing Innovation and Development in the Healthcare Sector 2024-01-04 17:37
GenScript Biotech Global Forum 2024 to Commence, Infusing New Vitality into the GCT Industry 2024-01-04 16:55
FDA Keynote Speaker in the Spotlight, CAR-T Industry Leaders Gather for Discussion-Join the 2024 GenScript Biotech Global Forum for a New Journey in Cell and Gene Therapy 2023-12-25 10:15
Titans Gather, Future Embarks: The GenScript Biotech Global Forum coinciding with the 2024 J.P. Morgan Healthcare Conference in San Francisco to Convene 20+ KOLs, Exploring Disruptive Transformations and Infinite Opportunities in GCT 2023-12-14 20:34
CRISPR Continuous to Innovate! Exploring the Future of Cell & Gene Therapy, Industry Leaders Converge at the 2024 GenScript Biotech Global Forum 2023-12-07 19:25
Genscript Biotech Reports 2022 Annual Results* 2023-03-31 08:40
Genscript Biotech Reports 2021 Annual Results 2022-03-20 22:47
GenScript Biotech Reports First Half 2021 Results 2021-08-24 21:38
Genscript Biotech Reports 2021 Interim Financial Results 2021-08-24 01:32
GenScript Biotech Reports Full Year 2020 Financial Results 2021-03-30 03:19
GenScript Biotech Reports Full Year 2020 Financial Results and Business Results 2021-03-30 01:35
Genscript Biotech Reports Full Year 2020 Financial Results 2021-03-27 02:16
Expanding Their Existing Strategic Collaboration, GenScript ProBio Licensed Global Rights to Develop and Commercialize a SMAB Bispecific Antibody Molecule to REMD Biotherapeutics Inc. 2020-09-17 22:00
GenScript Reports 2020 Interim Results and Provides Business Update 2020-08-31 11:32
GenScript launches CDMO segment "GenScript ProBio" at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum 2020-07-21 22:04
Duke-NUS, GenScript and A*STAR launch first-in-the-world SARS-CoV-2 serology test to detect neutralising antibodies without need of containment facility or specimen 2020-05-15 11:52
1 2 3